Header Logo

Connection

Gregory Clarke to Adolescent

Back to Details
This is a "connection" page, showing publications Gregory Clarke has written about Adolescent.
Gregory Clarke
Connection Strength
1.604
Adolescent
  1. Augmenting usual care SSRIs with cognitive behavioral therapy for insomnia to improve depression outcomes in youth: Design of a randomized controlled efficacy-effectiveness trial. Contemp Clin Trials. 2020 04; 91:105967.
    View in: PubMed
    Score: 0.099
  2. Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants. Pediatrics. 2018 02; 141(2).
    View in: PubMed
    Score: 0.085
  3. Cognitive Behavioral Therapy in Primary Care for Youth Declining Antidepressants: A Randomized Trial. Pediatrics. 2016 May; 137(5).
    View in: PubMed
    Score: 0.076
  4. Cognitive-behavioral treatment of insomnia and depression in adolescents: A pilot randomized trial. Behav Res Ther. 2015 Jun; 69:111-8.
    View in: PubMed
    Score: 0.070
  5. The complex role of sleep in adolescent depression. Child Adolesc Psychiatr Clin N Am. 2012 Apr; 21(2):385-400.
    View in: PubMed
    Score: 0.057
  6. Pain and sleep-wake disturbances in adolescents with depressive disorders. J Clin Child Adolesc Psychol. 2012; 41(4):482-90.
    View in: PubMed
    Score: 0.057
  7. Trends in youth antidepressant dispensing and refill limits, 2000 through 2009. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):11-20.
    View in: PubMed
    Score: 0.056
  8. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics. 2007 Nov; 120(5):e1313-26.
    View in: PubMed
    Score: 0.042
  9. Estimating the economic burden of depression in children and adolescents. Am J Prev Med. 2006 Dec; 31(6 Suppl 1):S143-51.
    View in: PubMed
    Score: 0.039
  10. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry. 2005 Sep; 44(9):888-98.
    View in: PubMed
    Score: 0.036
  11. Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry. 2003 May; 42(5):531-42.
    View in: PubMed
    Score: 0.031
  12. Stepped care for suicide prevention in teens and young adults: Design and methods of a randomized controlled trial. Contemp Clin Trials. 2022 12; 123:106959.
    View in: PubMed
    Score: 0.030
  13. Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):305-13.
    View in: PubMed
    Score: 0.028
  14. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001 Dec; 58(12):1127-34.
    View in: PubMed
    Score: 0.028
  15. Effects of an adolescent depression prevention program on maternal criticisms and positive remarks. J Fam Psychol. 2020 Dec; 34(8):927-937.
    View in: PubMed
    Score: 0.025
  16. The ReThink study: a 3-arm parallel randomized trial of cognitive bias modification, with and without adherence promotion, for adolescent anxiety disorder: trial design and protocol. BMC Psychiatry. 2019 10 22; 19(1):306.
    View in: PubMed
    Score: 0.024
  17. Psychosocial treatments for adolescent depression. Clin Psychol Rev. 1999 Apr; 19(3):329-42.
    View in: PubMed
    Score: 0.023
  18. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry. 1999 Mar; 38(3):272-9.
    View in: PubMed
    Score: 0.023
  19. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder. J ECT. 2018 Dec; 34(4):258-265.
    View in: PubMed
    Score: 0.023
  20. Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis. Med Care. 2018 05; 56(5):365-372.
    View in: PubMed
    Score: 0.022
  21. Prevention of Depression in At-Risk Adolescents: Moderators of Long-term Response. Prev Sci. 2018 02; 19(Suppl 1):6-15.
    View in: PubMed
    Score: 0.021
  22. Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression. Qual Life Res. 2018 02; 27(2):447-454.
    View in: PubMed
    Score: 0.021
  23. Does PTSD transcend cultural barriers? A study from the Khmer Adolescent Refugee Project. J Am Acad Child Adolesc Psychiatry. 1997 Jan; 36(1):49-54.
    View in: PubMed
    Score: 0.020
  24. Measuring Health-related Quality of Life in Teens With and Without Depression. Med Care. 2016 Dec; 54(12):1089-1097.
    View in: PubMed
    Score: 0.020
  25. Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Acad Child Adolesc Psychiatry. 2016 Mar; 55(3):219-26.
    View in: PubMed
    Score: 0.019
  26. Effect of a Cognitive-Behavioral Prevention Program on Depression 6 Years After Implementation Among At-Risk Adolescents: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Nov; 72(11):1110-8.
    View in: PubMed
    Score: 0.018
  27. Improving the transition from basic efficacy research to effectiveness studies: methodological issues and procedures. J Consult Clin Psychol. 1995 Oct; 63(5):718-25.
    View in: PubMed
    Score: 0.018
  28. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry. 1995 Mar; 34(3):312-21.
    View in: PubMed
    Score: 0.017
  29. Collaborative care for adolescents with depression in primary care: a randomized clinical trial. JAMA. 2014 Aug 27; 312(8):809-16.
    View in: PubMed
    Score: 0.017
  30. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ. 2014 Jun 18; 348:g3596.
    View in: PubMed
    Score: 0.017
  31. Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry. 2013 Nov; 70(11):1161-70.
    View in: PubMed
    Score: 0.016
  32. Evidence for the management of adolescent depression. Pediatrics. 2013 Oct; 132(4):e996-e1009.
    View in: PubMed
    Score: 0.016
  33. The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression. J Child Adolesc Psychopharmacol. 2013 Sep; 23(7):458-67.
    View in: PubMed
    Score: 0.016
  34. Longitudinal course and risk factors for fatigue in adolescents: the mediating role of sleep disturbances. J Pediatr Psychol. 2013 Nov; 38(10):1070-80.
    View in: PubMed
    Score: 0.016
  35. English language skills in a group of previously traumatized Khmer adolescent refugees. J Nerv Ment Dis. 1993 Jul; 181(7):454-6.
    View in: PubMed
    Score: 0.016
  36. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression. J Am Acad Child Adolesc Psychiatry. 2013 May; 52(5):482-92.
    View in: PubMed
    Score: 0.015
  37. The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression. J Am Acad Child Adolesc Psychiatry. 2013 Apr; 52(4):370-7.
    View in: PubMed
    Score: 0.015
  38. Reciprocal longitudinal associations between pain and depressive symptoms in adolescents. Eur J Pain. 2013 Aug; 17(7):1058-67.
    View in: PubMed
    Score: 0.015
  39. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry. 2012 Apr; 51(4):404-11.
    View in: PubMed
    Score: 0.014
  40. Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study. J Affect Disord. 2012 Apr; 138(1-2):86-95.
    View in: PubMed
    Score: 0.014
  41. Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):5-10.
    View in: PubMed
    Score: 0.014
  42. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):29-36.
    View in: PubMed
    Score: 0.014
  43. Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break. J Am Acad Child Adolesc Psychiatry. 2011 Nov; 50(11):1140-8.
    View in: PubMed
    Score: 0.014
  44. Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. J Am Acad Child Adolesc Psychiatry. 2011 Aug; 50(8):772-81.
    View in: PubMed
    Score: 0.013
  45. Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. J Am Acad Child Adolesc Psychiatry. 2011 May; 50(5):490-8.
    View in: PubMed
    Score: 0.013
  46. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry. 2011 Mar; 72(3):388-96.
    View in: PubMed
    Score: 0.013
  47. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Arch Gen Psychiatry. 2011 Mar; 68(3):253-62.
    View in: PubMed
    Score: 0.013
  48. Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. J Clin Psychopharmacol. 2011 Feb; 31(1):92-7.
    View in: PubMed
    Score: 0.013
  49. Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA). J Am Acad Child Adolesc Psychiatry. 2011 Mar; 50(3):293-301.
    View in: PubMed
    Score: 0.013
  50. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry. 2010 Jul; 167(7):782-91.
    View in: PubMed
    Score: 0.013
  51. Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry. 2010 Feb; 167(2):190-7.
    View in: PubMed
    Score: 0.012
  52. Substance use and the treatment of resistant depression in adolescents. J Am Acad Child Adolesc Psychiatry. 2009 Dec; 48(12):1182-92.
    View in: PubMed
    Score: 0.012
  53. Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings. J Consult Clin Psychol. 2009 Dec; 77(6):1033-41.
    View in: PubMed
    Score: 0.012
  54. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009 Jun 03; 301(21):2215-24.
    View in: PubMed
    Score: 0.012
  55. Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in Adolescents. J Consult Clin Psychol. 2009 Jun; 77(3):439-50.
    View in: PubMed
    Score: 0.012
  56. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry. 2009 Mar; 48(3):330-9.
    View in: PubMed
    Score: 0.012
  57. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry. 2009 Apr; 166(4):418-26.
    View in: PubMed
    Score: 0.011
  58. Using a website to build community and enhance outcomes in a group, multi-component intervention promoting healthy diet and exercise in adolescents. J Pediatr Psychol. 2009 Jun; 34(5):539-50.
    View in: PubMed
    Score: 0.011
  59. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008 Feb 27; 299(8):901-13.
    View in: PubMed
    Score: 0.011
  60. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, assessment, and initial management. Pediatrics. 2007 Nov; 120(5):e1299-312.
    View in: PubMed
    Score: 0.010
  61. What teens want: barriers to seeking care for depression. Adm Policy Ment Health. 2006 Mar; 33(2):133-45.
    View in: PubMed
    Score: 0.009
  62. Predicting time to recovery among depressed adolescents treated in two psychosocial group interventions. J Consult Clin Psychol. 2006 Feb; 74(1):80-8.
    View in: PubMed
    Score: 0.009
  63. Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry. 2005 Nov; 62(11):1241-8.
    View in: PubMed
    Score: 0.009
  64. Potential mediators of cognitive-behavioral therapy for adolescents with comorbid major depression and conduct disorder. J Consult Clin Psychol. 2005 Feb; 73(1):38-46.
    View in: PubMed
    Score: 0.009
  65. AACAP 2001 research forum: challenges and recommendations regarding recruitment and retention of participants in research investigations. J Am Acad Child Adolesc Psychiatry. 2004 Aug; 43(8):1037-45.
    View in: PubMed
    Score: 0.008
  66. AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2004 Aug; 43(8):1046-56.
    View in: PubMed
    Score: 0.008
  67. An efficacy/effectiveness study of cognitive-behavioral treatment for adolescents with comorbid major depression and conduct disorder. J Am Acad Child Adolesc Psychiatry. 2004 Jun; 43(6):660-8.
    View in: PubMed
    Score: 0.008
  68. Screening for anxiety and depression in early adolescence. J Am Acad Child Adolesc Psychiatry. 2001 Aug; 40(8):929-36.
    View in: PubMed
    Score: 0.007
  69. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001 Jul; 40(7):762-72.
    View in: PubMed
    Score: 0.007
  70. Impact of comorbidity on a cognitive-behavioral group treatment for adolescent depression. J Am Acad Child Adolesc Psychiatry. 2001 Jul; 40(7):795-802.
    View in: PubMed
    Score: 0.007
  71. Treated prevalence, incidence, and pharmacotherapy of child and adolescent mood disorders in an HMO. Ment Health Serv Res. 2001 Jun; 3(2):73-89.
    View in: PubMed
    Score: 0.007
  72. Mediating mechanisms in a program to reduce intentions to use anabolic steroids and improve exercise self-efficacy and dietary behavior. Prev Sci. 2001 Mar; 2(1):15-28.
    View in: PubMed
    Score: 0.007
  73. The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors. Arch Pediatr Adolesc Med. 2000 Apr; 154(4):332-8.
    View in: PubMed
    Score: 0.006
  74. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA. 1996 Nov 20; 276(19):1555-62.
    View in: PubMed
    Score: 0.005
  75. The Adolescents Training and Learning to Avoid Steroids (ATLAS) prevention program. Background and results of a model intervention. Arch Pediatr Adolesc Med. 1996 Jul; 150(7):713-21.
    View in: PubMed
    Score: 0.005
  76. The Khmer Adolescent Project: III. A study of trauma from Thailand's Site II refugee camp. J Am Acad Child Adolesc Psychiatry. 1996 Mar; 35(3):384-91.
    View in: PubMed
    Score: 0.005
  77. Multiple forms of stress in Cambodian adolescent refugees. Child Dev. 1996 Feb; 67(1):107-16.
    View in: PubMed
    Score: 0.005
  78. Psychosocial interventions for adolescent depression: issues, evidence, and future directions. Prog Behav Modif. 1996; 30:25-73.
    View in: PubMed
    Score: 0.005
  79. Posttraumatic stress disorder across two generations of Cambodian refugees. J Am Acad Child Adolesc Psychiatry. 1995 Sep; 34(9):1160-6.
    View in: PubMed
    Score: 0.005
  80. The Khmer Adolescent Project. II: Functional capacities in two generations of Cambodian refugees. J Nerv Ment Dis. 1995 Mar; 183(3):177-81.
    View in: PubMed
    Score: 0.004
  81. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994 Jul-Aug; 33(6):809-18.
    View in: PubMed
    Score: 0.004
  82. The Khmer Adolescent Project. I. Epidemiologic findings in two generations of Cambodian refugees. J Nerv Ment Dis. 1994 Jul; 182(7):387-95.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente